1-([1,2,4]TRIAZOLO[4,3-A]PYRIDIN-3-YL)-N-METHYLMETHANAMINE HCL, 95.0%, 250mg

2-BROMO-6-(TRIFLUOROMETHYL)BENZO[D]THIAZOLE, 95%, 1g

2-Amino-4,5,6,7-tetrahydro-benzo[b]thiophene-3-carbonitrile, 97.0%, 5g

3-((DIMETHYLAMINO)METHYL)-1H-INDOLE-6-CARBONITRILE, 95.0%, 5g

(2R,6S)-2-allyl-6-phenyl-1,2,3,6-tetrahydropyridine, 95.0%, 1g

(6S)-6-[4-(morpholin-4-yl)phenyl]-6-(thiophen-3-yl)piperidine-2,4-dione, 97%, 100mg

2,6-Dihydroxybenzoic Acid>98.0%(GC)(T)25g

(3R,11bR)-3-Isobutyl-9,10-dimethoxy-3,4,6,7-tetrahydro-1H-pyrido[2,1-a]isoquinolin-2(11bH)-one, 95.0%, 5mg

Methyl 2-oxo-1,2-dihydropyrimidine-4-carboxylate, 95.0%, 5g

1,4-Diiodobutane, 95.0%, 500g

1,3,5-Tris(bromomethyl)-2,4,6-triethylbenzene, 95.0%, 5g

6-Fluoro-1H-benzoimidazole-2-carbaldehyde, 95.0%, 250mg

Acide gallique monohydraté, min 99%, 100 g, emballage plastique.